Automated insulin delivery systems have, for the first time, been tested for people with type-one diabetes and end-stage kidney disease. The results found that they were safe and able to offer improvements in managing the patient's blood glucose.
from Medical Xpress - latest medical and health news stories https://ift.tt/iayzgL9
